Blood Pressure Variability and Ischemic Stroke Outcome
Part of paid clinical trials in New Haven, Connecticut.
- Sponsor
- Yale University
- Study ID
- NCT05756257
- Status
- Recruiting
Conditions
- Acute Ischemic Stroke
- Blood Pressure Variability
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to evaluate the role of blood pressure (BPV) variability in patients suffering from acute ischemic stroke. The main questions it aims to answer are: 1. To determine the association of BPV with functional/cognitive outcome after ischemic stroke. 2. To determine a pathophysiologic mechanism of BPV's deleterious effect on functional outcome. 3. To evaluate potential treatment targets to pharmacologically reduce BPV after ischemic stroke.
Key Dates
- Start date
- Jul 15, 2024
- Status verified
- May 2026
- Primary completion
- Jul 30, 2026
- Completion
- Jul 30, 2026
Study Design
- Enrollment
- 150 participants (estimated)
Arms
- Arm: Acute Ischemic StrokeBlood pressure variability will be measured in the patients with acute ischemic stroke.
Primary Outcome Measure
Change in Functional outcome [ Time Frame: 90 days and 1 Year ]
Central Contacts
- Adam de Havenon, MD203-785-4085
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Yale-New Haven Hospital | New Haven | Connecticut | 06510 | Alison Champagne, MD Adam de Havenon, MD (PRINCIPAL_INVESTIGATOR) |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | Shyam Prabhakaran, MD |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | W. Taylor Kimberly, MD, PhD |
Find similar trials in New Haven, CT
By condition
By specialty
Related Studies
- Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy TrialPHASE3 · Recruiting · Mercy Health Ohio · Mobile, Alabama
- The Pivotal Study of RapidPulseTM Aspiration SystemRecruiting · RapidPulse, Inc · Torrance, California
- Optimizing Reperfusion to Improve Outcomes and Neurologic FunctionPHASE2/PHASE3 · Recruiting · Corxel Pharmaceuticals · Long Beach, California
- Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known WellRecruiting · Amrou Sarraj · Chicago, Illinois